[Isoprinosine in the treatment of herpesvirus infections in children with leukemia and malignant lymphoma]. 1983

M Ochocka, and D Chmielewska, and M Matysiak

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D007542 Inosine Pranobex An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly. Inosiplex,Methisoprinol,Imunovir,Isoprinosin,Isoprinosine,Methysoprinol,Metisoprinol,NPT-10381,NPT 10381,NPT10381,Pranobex, Inosine
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Ochocka, and D Chmielewska, and M Matysiak
February 1973, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Ochocka, and D Chmielewska, and M Matysiak
January 1986, Klinische Padiatrie,
M Ochocka, and D Chmielewska, and M Matysiak
July 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M Ochocka, and D Chmielewska, and M Matysiak
October 1971, Journal of the National Cancer Institute,
M Ochocka, and D Chmielewska, and M Matysiak
January 1987, International journal of immunopharmacology,
M Ochocka, and D Chmielewska, and M Matysiak
February 1974, Antimicrobial agents and chemotherapy,
M Ochocka, and D Chmielewska, and M Matysiak
January 1982, Developments in biological standardization,
M Ochocka, and D Chmielewska, and M Matysiak
November 1976, Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Ochocka, and D Chmielewska, and M Matysiak
September 1981, Pediatria polska,
M Ochocka, and D Chmielewska, and M Matysiak
May 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!